Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
CAG repeat
Huntington disease
age of onset
genetic modifier
loss of interruption
polyglutamine
reduced penetrance alleles
somatic instability
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
06 06 2019
06 06 2019
Historique:
received:
30
01
2019
accepted:
10
04
2019
pubmed:
21
5
2019
medline:
12
3
2020
entrez:
21
5
2019
Statut:
ppublish
Résumé
Huntington disease (HD) is caused by a CAG repeat expansion in the huntingtin (HTT) gene. Although the length of this repeat is inversely correlated with age of onset (AOO), it does not fully explain the variability in AOO. We assessed the sequence downstream of the CAG repeat in HTT [reference: (CAG)n-CAA-CAG], since variants within this region have been previously described, but no study of AOO has been performed. These analyses identified a variant that results in complete loss of interrupting (LOI) adenine nucleotides in this region [(CAG)n-CAG-CAG]. Analysis of multiple HD pedigrees showed that this LOI variant is associated with dramatically earlier AOO (average of 25 years) despite the same polyglutamine length as in individuals with the interrupting penultimate CAA codon. This LOI allele is particularly frequent in persons with reduced penetrance alleles who manifest with HD and increases the likelihood of presenting clinically with HD with a CAG of 36-39 repeats. Further, we show that the LOI variant is associated with increased somatic repeat instability, highlighting this as a significant driver of this effect. These findings indicate that the number of uninterrupted CAG repeats, which is lengthened by the LOI, is the most significant contributor to AOO of HD and is more significant than polyglutamine length, which is not altered in these individuals. In addition, we identified another variant in this region, where the CAA-CAG sequence is duplicated, which was associated with later AOO. Identification of these cis-acting modifiers have potentially important implications for genetic counselling in HD-affected families.
Identifiants
pubmed: 31104771
pii: S0002-9297(19)30153-3
doi: 10.1016/j.ajhg.2019.04.007
pmc: PMC6556907
pii:
doi:
Substances chimiques
Codon
0
Peptides
0
polyglutamine
26700-71-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1116-1126Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
Copyright © 2019 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Références
Neurology. 2000 Jan 25;54(2):491-3
pubmed: 10668721
Genet Test. 2000;4(1):55-60
pubmed: 10794362
Clin Genet. 2000 Dec;58(6):469-72
pubmed: 11149616
J Med Genet. 2001 Apr;38(4):E12
pubmed: 11283208
Hum Mol Genet. 2001 Jul 1;10(14):1441-8
pubmed: 11448935
Am J Med Genet. 2001 Jul 8;105(5):399-403
pubmed: 11449389
Brain. 2001 Oct;124(Pt 10):1939-47
pubmed: 11571212
Hum Mol Genet. 2003 Dec 15;12(24):3359-67
pubmed: 14570710
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503
pubmed: 14993615
Clin Genet. 2004 Apr;65(4):267-77
pubmed: 15025718
Hum Mol Genet. 2007 May 15;16(10):1133-42
pubmed: 17409200
Neurology. 2007 Nov 20;69(21):1970-5
pubmed: 17568014
Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):314-20
pubmed: 19455596
Hum Mol Genet. 2009 Aug 15;18(16):3039-47
pubmed: 19465745
Genome Med. 2009 Aug 21;1(8):80
pubmed: 19725930
Hum Mol Genet. 2012 May 15;21(10):2219-32
pubmed: 22328089
J Med Genet. 2013 Oct;50(10):696-703
pubmed: 23896435
Am J Med Genet B Neuropsychiatr Genet. 2013 Dec;162B(8):864-71
pubmed: 24038799
PLoS Genet. 2013 Oct;9(10):e1003930
pubmed: 24204323
Nat Neurosci. 2015 Jun;18(6):807-16
pubmed: 25938884
Mol Ther. 2015 Nov;23(11):1759-1771
pubmed: 26201449
Cell. 2015 Jul 30;162(3):516-26
pubmed: 26232222
Am J Hum Genet. 2016 Feb 4;98(2):287-98
pubmed: 26849111
Neurology. 2016 Jul 19;87(3):282-8
pubmed: 27335115
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Nat Neurosci. 2017 Apr;20(4):602-611
pubmed: 28263302
Lancet Neurol. 2017 Sep;16(9):701-711
pubmed: 28642124
Genome Res. 2017 Nov;27(11):1895-1903
pubmed: 28887402
Bioinformatics. 2019 May 27;:null
pubmed: 31134279
J Med Genet. 1995 May;32(5):399-400
pubmed: 7616551
Hum Mol Genet. 1995 Feb;4(2):189-95
pubmed: 7757066
Nat Genet. 1994 Apr;6(4):409-14
pubmed: 8054984
Hum Mol Genet. 1995 Oct;4(10):1911-8
pubmed: 8595415
Hum Mol Genet. 1997 Feb;6(2):301-9
pubmed: 9063751